Riskpilot← Back to searchSign inGet full accessDoc Mäenkulma Oy
OYActiveY-tunnus 2357776-9Väättyrintie 2Medical specialists activities · NACE 8622Est. 20101 employees
Revenue 2025
EUR 152K
-12% vs 2024
EBITDA margin
38.9%
-17% vs 2024
Equity ratio
97.4%
Financial strength
Net profit 2025
EUR 33K
-27% vs 2024
| Revenue | EUR 152K | -12% |
| EBITDA | EUR 59K | -17% |
| Net profit | EUR 33K | -27% |
| Total assets | EUR 303K | +3% |
| Equity | EUR 295K | +4% |
| Employees | 1 | — |
Legal name
Doc Mäenkulma Oy
Y-tunnus number
2357776-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. syyskuuta 2010
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on sosiaali- ja terveyspalvelujen tuottaminen sekä em. alojen koulutus ja konsultointi. Yhtiö voi omistaa ja hallita kiinteistöjä ja osakkeita sekä käydä näillä kauppaa.
Address
Väättyrintie 2
Phone
+3580405115007
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 160 | 176 | 156 | 173 | 152 |
| Staff expenses | −58 | −42 | −26 | −46 | −40 |
| EBITDA | 54 | 83 | 81 | 71 | 59 |
| Depreciation & amort. | −8 | −22 | −18 | −14 | −18 |
| EBIT | 46 | 61 | 63 | 57 | 42 |
| Net financials | −0 | −0 | −0 | 0 | 0 |
| Profit before tax | 46 | 61 | 63 | 57 | 42 |
| Tax | 9 | 12 | 13 | 12 | 8 |
| Net profit | 37 | 49 | 50 | 46 | 33 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 204 | 234 | 268 | 293 | 303 |
| Equity | 193 | 226 | 259 | 284 | 295 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 11 | 8 | 9 | 9 | 8 |
| Total debt | 11 | 8 | 9 | 9 | 8 |
EBITDA margin
38.9%
This company
15.8%
Market median
+146% vs market
20212025
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
20212025
Return on equity
11.3%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
21.9%
This company
8.1%
Market median
+170% vs market
20212025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HS Deputy Member | Deputy Member | 2010 |
ST Chief Executive Officer | Chief Executive Officer | 2010 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doc Mäenkulma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Saara Elisabeth Stüber Pakkala | Deputy Member | 0 companies |
| Sami Tapani Pakkala | Chief Executive Officer | 0 companies |